| Dr Gerard A Kuhn, MD | |
|
Nemours Pediatrics Middletown, 200 Cleaver Farm Road Suite 201, Middletown, DE 19709-1630 | |
| (302) 378-5100 | |
| (302) 378-5106 |
| Full Name | Dr Gerard A Kuhn |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | Nemours Pediatrics Middletown, Middletown, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851482236 | NPI | - | NPPES |
| 39161 | Medicaid | NJ | |
| 101023441 | Medicaid | PA | |
| 4058267 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | C10007351 (Delaware) | Secondary |
| 208D00000X | General Practice | C10007351 (Delaware) | Primary |
| Entity Name | The Nemours Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366594699 PECOS PAC ID: 9537072483 Enrollment ID: O20040422000840 |
News Archive
"Long heralded as a model for the global response to HIV/AIDS, Brazil is intensifying its actions, at home and abroad, in the face of potential setbacks including an arising need for new treatment regimens, the resultant increase in drug prices and the debate over intellectual property rights," Inter Press Service reports.
Prana Biotechnology Limited has announced that it has identified novel therapeutic drug candidates from its Parkinson's disease program. Already, a lead candidate drug has demonstrated positive effects in pre-clinical studies, protecting the brain from damage to the substantia nigra, the area of the brain affected in Parkinson's disease.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the wide-scale availability of its advanced analytical offering, IMS Specialty Market Dynamics™, which delivers the most complete view of treatment patterns and product performance in the rapidly growing specialty pharmaceutical market.
Scientists have been studying ways to use synthetic DNA as a building block for smaller and faster devices. DNA has the advantage of being inherently "coded". Each DNA strand is formed of one of four "codes" that can link to only one complementary code each, thus binding two DNA strands together.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gerard A Kuhn, MD Po Box 191, Provider Enrollment Dept, Rockland, DE 19732-0191 Ph: (302) 651-6212 | Dr Gerard A Kuhn, MD Nemours Pediatrics Middletown, 200 Cleaver Farm Road Suite 201, Middletown, DE 19709-1630 Ph: (302) 378-5100 |
News Archive
"Long heralded as a model for the global response to HIV/AIDS, Brazil is intensifying its actions, at home and abroad, in the face of potential setbacks including an arising need for new treatment regimens, the resultant increase in drug prices and the debate over intellectual property rights," Inter Press Service reports.
Prana Biotechnology Limited has announced that it has identified novel therapeutic drug candidates from its Parkinson's disease program. Already, a lead candidate drug has demonstrated positive effects in pre-clinical studies, protecting the brain from damage to the substantia nigra, the area of the brain affected in Parkinson's disease.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the wide-scale availability of its advanced analytical offering, IMS Specialty Market Dynamics™, which delivers the most complete view of treatment patterns and product performance in the rapidly growing specialty pharmaceutical market.
Scientists have been studying ways to use synthetic DNA as a building block for smaller and faster devices. DNA has the advantage of being inherently "coded". Each DNA strand is formed of one of four "codes" that can link to only one complementary code each, thus binding two DNA strands together.
› Verified 6 days ago